Hunan Jiudian Pharmaceutical (300705) Revenue Breakdown - Main Composition

14.86
-0.15-1.00%

Market Closed Mar 11 15:00 CST

7.43BMarket Cap15.86P/E (TTM)

Hunan Jiudian Pharmaceutical (300705) Revenue Breakdown Overview

By Product

Currency:CNY

2025/H1

Stock NameRevenueRatio

Pharmaceutical preparation1.25B82.47%

Raw material medicine115.7M7.65%

Medicinal excipients91.14M6.03%

Extracts and others47.82M3.16%

Technology transfer and services9.53M0.63%

Other business787.47K0.05%

View all

By Industry

Currency:CNY

2022/FY

Stock NameRevenueRatio

Main business2.33B99.96%

Other business893.62K0.04%

By Country/Region

Currency:CNY

2025/H1

Stock NameRevenueRatio

East China region553.21M36.59%

Central China257.18M17.01%

Southwest area189.32M12.52%

South China188.4M12.46%

North China158.55M10.49%

Northwest region87.99M5.82%

Northeast area47.61M3.15%

Abroad28.9M1.91%

Other business787.47K0.05%

View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Recently, the ongoing conflict between the US and Iran has continued to impact the stock market. Previously, there were indications that Tru Show More

富哥搞钱

Feb 28 17:22

Breaking! The US and Israel jointly bombed Iran. What will be the stock market trend next week?

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.